在帕金森病患者中优化住院药物管理:关于药房技术和工作流程的建议
Jeryl Ritzi T Yu1,2, Brent S Sokola3, Benjamin L Walter4
1St. Luke's Medical Center, Institute for Neurosciences, Quezon City, Philippines.
Frontiers in pharmacology
|November 30, 2023
概括
入院帕金森病 (PD) 患者面临药物错误的风险. 药剂师可以通过确保及时服用利沃多巴和避免某些药物相互作用来改善护理.
科学领域:
- 神经学 神经学
- 临床药房 临床药房
- 患者安全 患者安全
背景情况:
- 帕金森病 (PD) 患者在住院期间是脆弱的.
- 急性疾病或药物变化可能导致PD患者的失补偿.
- 并发症通常是由于运动/非运动症状恶化和不准确的药物治疗方案而引起的.
研究的目的:
- 突出改善住院PD患者药物治疗的关键领域.
- 为尽量减少与药物相关的并发症提供建议.
- 强调医院药剂师在PD患者护理中的作用.
主要方法:
- 对药房管理抗帕金森症药物的药房策略的审查.
- 专注于及时服用含有勒沃多巴的药物.
- 强调减少药物替代,省略和避免使用抗多巴胺作用剂.
主要成果:
- 不准确的药物治疗方案是PD患者住院并发症的常见原因.
- 药房干预可以优化药物管理.
- 策略包括及时输送利沃多巴,避免使用禁忌药物.
结论:
- 医院药剂师在优化PD患者的药物治疗中发挥着不可或缺的作用.
- 实施特定的药房策略可以显著改善患者的安全和结果.
- 解决药物管理对于减少PD住院相关风险至关重要.
相关概念视频
Parkinson's Disease: Treatment
276
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
276
Drug Therapy
45
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
45
Parkinson's Disease: Overview
557
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
557
Drug Dosage Regimen: Overview
3.6K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.6K
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
65
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
65
Psychosis: Goals of Pharmacotherapy
142
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
142


